Hepatotoxicity During Treatment for Multidrug-Resistant Tuberculosis: Occurrence, Management and Outcome

International Journal of Tuberculosis and Lung Disease - France
doi 10.5588/ijtld.11.0591
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Union Against Tuberculosis and Lung Disease

Related search

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Impact of Diabetes Mellitus on Treatment Outcome of Multidrug Resistant Pulmonary Tuberculosis

Journal of Evolution of Medical and Dental Sciences
2018English

Predictors of Unfavourable Treatment Outcome in Patients With Multidrug-Resistant Tuberculosis in India

Public Health Action
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Multidrug Resistant Tuberculosis – Biomechanism, Epidemiology and Management Strategies

Medical Journal Armed Forces India
Medicine
1997English

Bedaquiline: New Approach for Treatment of Multidrug-Resistant Tuberculosis

RUHS Journal of Health Science
2019English

Hypokalemia Among Patients Receiving Treatment for Multidrug-Resistant Tuberculosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

Therapeutic Drug Management: Is It the Future of Multidrug-Resistant Tuberculosis Treatment?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy